Compare ENR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENR | MRVI |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2015 | 2020 |
| Metric | ENR | MRVI |
|---|---|---|
| Price | $21.63 | $6.80 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $22.17 | $8.50 |
| AVG Volume (30 Days) | 851.7K | ★ 2.3M |
| Earning Date | 11-17-2026 | 11-04-2026 |
| Dividend Yield | ★ 5.46% | N/A |
| EPS Growth | ★ 538.46 | 14.29 |
| EPS | ★ 3.32 | N/A |
| Revenue | ★ $2,952,700,000.00 | $185,743,000.00 |
| Revenue This Year | $0.38 | $14.01 |
| Revenue Next Year | N/A | $6.20 |
| P/E Ratio | $6.63 | ★ N/A |
| Revenue Growth | ★ 2.28 | N/A |
| 52 Week Low | $15.75 | $2.55 |
| 52 Week High | $25.35 | $9.42 |
| Indicator | ENR | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 50.14 | 43.68 |
| Support Level | $19.68 | $6.49 |
| Resistance Level | $22.76 | $7.60 |
| Average True Range (ATR) | 0.80 | 0.45 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 62.79 | 17.71 |
Energizer Holdings Inc. manufactures and distributes household batteries, specialty batteries, and lighting products. The company offers batteries using lithium, alkaline, carbon zinc, nickel metal hydride, zinc air, and silver oxide technologies, sold under the Energizer, Rayovac, Varta, and Eveready brands across performance and premium price segments. It also provides auto care products in the appearance, fragrance, performance, and air conditioning recharge categories. Energizer operates through two geographical segments, the United States and International, with the majority of its revenue generated in the United States. It has two product segments: Batteries and Lights and Auto Care, with the Batteries and Lights segment contributing the majority of its revenue.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.